MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 20.921
EU - Europa 13.805
AS - Asia 9.515
SA - Sud America 1.385
AF - Africa 283
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 18
Totale 46.024
Nazione #
US - Stati Uniti d'America 20.416
IT - Italia 7.016
SG - Singapore 2.938
GB - Regno Unito 2.412
CN - Cina 2.359
HK - Hong Kong 1.068
BR - Brasile 1.028
SE - Svezia 977
VN - Vietnam 969
DE - Germania 616
FR - Francia 550
FI - Finlandia 530
UA - Ucraina 377
TR - Turchia 376
RU - Federazione Russa 374
BD - Bangladesh 308
KR - Corea 275
IN - India 261
CA - Canada 238
JP - Giappone 224
NL - Olanda 204
ID - Indonesia 199
MX - Messico 193
IE - Irlanda 162
BG - Bulgaria 161
AR - Argentina 134
AU - Australia 89
ZA - Sudafrica 89
IQ - Iraq 76
PK - Pakistan 76
PL - Polonia 75
AE - Emirati Arabi Uniti 63
TN - Tunisia 58
EC - Ecuador 54
ES - Italia 49
MY - Malesia 49
CH - Svizzera 43
CL - Cile 42
LT - Lituania 42
CO - Colombia 39
BE - Belgio 35
PH - Filippine 34
IR - Iran 33
SA - Arabia Saudita 33
EG - Egitto 31
MA - Marocco 31
AT - Austria 28
PE - Perù 28
VE - Venezuela 28
UZ - Uzbekistan 23
RO - Romania 22
TH - Thailandia 22
JO - Giordania 21
DZ - Algeria 20
BZ - Belize 19
HU - Ungheria 19
KE - Kenya 19
NP - Nepal 19
EU - Europa 16
PT - Portogallo 15
TW - Taiwan 15
PY - Paraguay 14
DK - Danimarca 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
BO - Bolivia 10
IL - Israele 10
HR - Croazia 9
RS - Serbia 9
GR - Grecia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
AL - Albania 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
HN - Honduras 7
LV - Lettonia 7
KG - Kirghizistan 6
LB - Libano 6
LU - Lussemburgo 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
BY - Bielorussia 5
CY - Cipro 5
KZ - Kazakistan 5
QA - Qatar 5
SI - Slovenia 5
UY - Uruguay 5
CR - Costa Rica 4
KW - Kuwait 4
NI - Nicaragua 4
GT - Guatemala 3
GY - Guiana 3
JM - Giamaica 3
ML - Mali 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
Totale 45.976
Città #
Singapore 2.024
Santa Clara 2.005
Ashburn 1.742
Fairfield 1.722
Southend 1.515
Hong Kong 1.038
Woodbridge 941
Chandler 917
Houston 757
San Jose 749
Chicago 659
Wilmington 637
Hefei 619
Seattle 589
Jacksonville 566
Cambridge 533
Milan 533
Ann Arbor 531
Los Angeles 518
Nyköping 513
Rome 471
Council Bluffs 463
London 447
Beijing 418
Helsinki 407
Dearborn 387
The Dalles 348
New York 310
Ho Chi Minh City 291
Salt Lake City 274
Modena 245
Seoul 236
Hanoi 233
San Diego 182
Izmir 181
Dallas 155
Sofia 152
Princeton 147
Jakarta 135
Redwood City 132
Tampa 130
Dublin 127
Bologna 125
Lauterbourg 122
Buffalo 120
Elk Grove Village 119
Florence 119
Eugene 113
Shanghai 112
Naples 111
São Paulo 107
Bari 103
Palermo 103
Moscow 100
Frankfurt am Main 97
Tokyo 97
Catania 82
Bremen 77
Falls Church 71
Genoa 70
Orem 69
Boardman 66
Toronto 65
Mexico City 64
Verona 61
Des Moines 57
Sterling 57
Turin 57
Munich 56
Columbus 55
Da Nang 54
Phoenix 54
Lancaster 51
Padova 50
Chennai 47
Perth 47
Miami 45
Guangzhou 44
Montreal 42
Atlanta 41
Johannesburg 41
Manchester 40
Cagliari 39
San Francisco 39
Brooklyn 38
Warsaw 38
Denver 37
Parma 36
Amsterdam 35
Mumbai 35
Dulles 34
Paris 34
Ankara 33
Haiphong 32
Ottawa 31
Redondo Beach 31
Dong Ket 30
Salerno 30
Messina 29
Brescia 28
Totale 28.599
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.841
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.360
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.297
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 955
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 693
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 470
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 453
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 441
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 434
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 414
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 403
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 386
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 384
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 378
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 373
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 372
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 365
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 361
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 358
Current treatment of hepatitis C-associated rheumatic diseases. 354
Cardiac Involvement in Systemic Vasculitis 350
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 349
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 346
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 346
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 346
Scleroderma digital ulcers complicated by infection with fecal pathogens. 344
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 344
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 342
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 336
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 324
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 321
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 321
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 319
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 317
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 316
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 308
Acute exacerbation of interstitial lung disease associated with rheumatic disease 308
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 307
Platelet gel in the treatment of severe scleroderma skin ulcers. 307
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 306
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 305
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 303
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 302
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 299
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 297
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 291
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 291
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 286
Cardiovascular risk and prostanoids in systemic sclerosis 284
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 284
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 282
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 282
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 280
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 277
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 274
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 273
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 272
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 272
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 272
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 270
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 257
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 254
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 252
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 252
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 248
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 248
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 245
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 244
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 242
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 240
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 240
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 237
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 234
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 233
Osteomyelitis complicating scleroderma digital ulcers. 232
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 230
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 228
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 228
Procedural pain management in the treatment of scleroderma digital ulcers 227
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 227
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 226
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 226
Nailfold videocapillaroscopy in antisynthetase syndrome 224
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 222
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 219
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 217
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 215
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 214
A new chance to treat rheumatoid arthritis lung fibrosis? 213
Mixed cryoglobulinemia syndrome: where are we going to? 213
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 213
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 209
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 208
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 204
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 203
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 202
Totale 35.744
Categoria #
all - tutte 171.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 0 0 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/202614.781 800 516 1.011 2.020 3.042 1.045 1.737 647 1.320 1.171 1.098 374
Totale 46.477